CVRs. As provided in the Merger Agreement, effective as of the Effective Time, (i) each Share shall be converted into the right to receive the Merger Consideration, which includes one CVR, and (ii) each Company Warrant that is assumed and converted pursuant to Section 5.3(c) of the Merger Agreement shall be treated in accordance with its terms. The initial Holders shall be determined pursuant to the terms of the Merger Agreement and this Agreement, and a list of the initial Holders shall be furnished to the Rights Agent by or on behalf of Parent in accordance with Section 4.1 hereof.
Appears in 12 contracts
Samples: Contingent Value Rights Agreement (Tetraphase Pharmaceuticals Inc), Contingent Value Rights Agreement (Acelrx Pharmaceuticals Inc), Agreement and Plan of Merger (Acelrx Pharmaceuticals Inc)
